• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-K filed by PACS Group Inc.

    4/1/25 8:23:06 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    NT 10-K 1 pacsgroupinc12b-25xq420241.htm NT 10-K Document


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM 12b-25
     
    NOTIFICATION OF LATE FILING
     
    SEC File Number: 001-42011
    CUSIP Number: 69380Q107
     
    (Check one): 
    ☒ Form 10-K
    ☐ Form 20-F
    ☐ Form 11-K
    ☐ Form 10-Q
    ☐ Form 10-D
      
    ☐ Form N-SAR
    ☐ Form N-CSR
       
           
      For Period Ended:December 31, 2024
      
    ☐ Transition Report on Form 10-K
      
      
    ☐ Transition Report on Form 20-F
      
      
    ☐ Transition Report on Form 11-K
      
      
    ☐ Transition Report on Form 10-Q
      
      
    ☐ Transition Report on Form N-SAR
      
      For the Transition Period Ended:
     
    Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.
     
    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: Not Applicable
     






    PART I - REGISTRANT INFORMATION
     
    PACS GROUP, INC.
    Full Name of Registrant
     
    N/A
    Former Name if Applicable
     
    262 N. University Avenue
    Address of Principal Executive Office (Street and Number)
     
    Farmington, UT 84025
    City, State and Zip Code
     
    PART II - RULES 12b-25(b) AND (c)
     
    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     ☒
    (a)The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
    ☐(b)The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
     ☐
    (c)The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
     
    PART III - NARRATIVE
    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

    As disclosed in PACS Group, Inc.’s (the “Company”) press release issued on November 6, 2024, furnished as Exhibit 99.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 6, 2024, the Company’s independent Audit Committee, with assistance from external counsel, is conducting an independent investigation of recent third-party allegations. The Company and its personnel have been and continue to be cooperating in the investigation, and the Audit Committee has made substantial progress towards reaching conclusions from the investigation. On November 15, 2024, the Company filed a Form 12b-25 notifying the United States Securities and Exchange Commission (the "SEC") that the Company would be unable to timely file its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024. As a result of the ongoing Audit Committee investigation, the Company has determined that it will not be able, without unreasonable effort or expense, to file its Annual Report on Form 10-K for the year ended December 31, 2024 by the prescribed due date for such annual report. The Company intends to file its Annual Report on Form 10-K for the year ended December 31, 2024 as soon as practicable, following or concurrent with the Company's filing of the Quarterly Report on Form 10-Q for the quarter ended September 30, 2024.

    Forward-Looking Statements
    This Notification of Late Filing on Form 12b-25 contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as



    amended. Words such as “expect,” “will,” “anticipates,” “estimates” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. These forward-looking statements include, but are not limited to, statements regarding the Company’s expectations regarding the timing the completion of the ongoing investigation and the timing of and its ability to make the Company’s Form 10-K filing. Forward-looking statements are based on management’s current expectations based on information currently available to the Company. Forward-looking statements are subject to known and unknown risks, uncertainties and assumptions, and actual results or outcomes may differ materially from those expressed or implied in the forward-looking statements due to various important factors, including, but not limited to the important factors discussed under the caption “Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024, as any such factors may be updated from time to time in the Company’s other filings with the SEC. All forward-looking statements speak only as of the date of this Notification of Late Filing on Form 12b-25 and, except as required by applicable law, the Company has no obligation to update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

    PART IV - OTHER INFORMATION

    (1)Name and telephone number of person to contact in regard to this notification
     Derick Apt 801 447-9827
     (Name) (Area Code) (Telephone Number)
      
    (2)
    Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).
    The Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 has not been filed.
      
         
    ☐Yes ☒No
     
    (3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
      
         
    ☐ Yes ☒No
      
    If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     







    PACS GROUP, INC.
    (Name of Registrant as Specified in Charter)

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
     
    DateApril 1, 2025 By/s/ Derick Apt
       Name: Derick Apt
    Title: Chief Financial Officer




    Get the next $PACS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2025$44.00Overweight
    Analyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

    1/20/26 5:41:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. to Present at Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026, at 5:15 p.m., Pacific Time

    PACS Group, Inc. (NYSE:PACS) announced today that Jason Murray, Chairman and Chief Executive Officer, and Mark Hancock, Executive Vice President and Interim Chief Financial Officer, will present at the annual J.P. Morgan Healthcare Conference in San Francisco. The presentation audio will be webcast live on Tuesday, January 13, 2026, at 5:15 pm Pacific Time. To access the live webcast, please visit the Investor Relations section of PACS's website at https://ir.pacs.com or at https://ir.pacs.com/news-events/ir-calendar. An archived version of the webcast will be available for at least 30 days following the presentation. About PACS™ PACS Group, Inc. is a holding company investing in post-a

    1/12/26 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Expands Management Team, Adding New Chief Compliance Officer and Chief Human Resource Officer to Executive Leadership Team

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announces the appointments of Kelly Priegnitz as Chief Compliance Officer and Trent Bingham as Chief Human Resources Officer. Mr. Bingham joined PACS on Nov. 10, while Ms. Priegnitz began her role on Dec. 1. Ms. Priegnitz joins PACS after serving as Executive Vice President and Chief Legal and Compliance Officer of Pinnacle Treatment Centers since 2020. Prior to her service at Pinnacle Treatment Centers, Ms. Priegnitz held a variety of senior healthcare compliance leadership roles throughout her career, including Senior Vic

    12/8/25 4:12:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on PACS Group with a new price target

    Analyst resumed coverage of PACS Group with a rating of Overweight and set a new price target of $44.00

    12/17/25 9:24:40 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    SEC Filings

    View All

    PACS Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/23/25 4:02:39 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - PACS Group, Inc. (0002001184) (Filer)

    12/1/25 4:02:18 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form DEF 14A filed by PACS Group Inc.

    DEF 14A - PACS Group, Inc. (0002001184) (Filer)

    11/25/25 4:03:34 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 3,348 shares, decreasing direct ownership by 0.89% to 374,870 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:59:36 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Legal Officer & Sec. Mitchell John Todd covered exercise/tax liability with 9,541 shares, decreasing direct ownership by 1% to 868,150 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:58:47 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    President & COO Jergensen Joshua covered exercise/tax liability with 21,998 shares, decreasing direct ownership by 0.81% to 2,703,682 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    1/20/26 4:57:41 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group Announces the Acquisition of Three Post-Acute Operations and the Real Estate of Four Facilities

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company") today announced that independently operated subsidiaries of the Company have acquired the operations of three post-acute care facilities, two located in Alaska and one in Idaho, representing a total of 230 beds. The facilities are located in the Kenai Peninsula region of Alaska and the Boise metropolitan area of Idaho. The Company acquired the real estate associated with the two Alaska facilities, while the Idaho facility will operate under a lease arrangement with a third-party landlord. In addition, PACS recently acquired the real estate for two existing skilled nursing operations: Sierra Valley Rehab Center in Porterville, Californ

    1/20/26 5:41:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces Business Updates

    Entered into Amendment and Waiver to Existing Credit Agreement Acquires Operations and Real Estate of 160-Bed Skilled Nursing Facility in Nevada PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced several business updates that build on the Company's momentum and strong year-to-date operational and financial performance. "The amendment and waiver to our credit agreement and the latest addition to our growing portfolio demonstrate how our team continues to execute on our strategy and position our business for continued growth," said Jason Murray, PACS's Chief Execu

    12/1/25 4:15:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care